Table 4. Pharmaceutical financial sponsoring.
Statement | Strongly disagree, n (%) | Disagree, n (%) | Neutral, n (%) | Agree, n (%) | Strongly agree, n (%) |
It is acceptable that a medical Professor receive money from drug companies for medical congress (n = 624) | 143 (22.9) | 110 (17.6) | 152 (24.4) | 148 (23.7) | 71 (11.4) |
Since students from non-medical universities are invited to meetings and meals by private companies, medical residents should be allowed to attend similar arrangements with pharmaceutical industry (n = 627) | 79 (12.6) | 72 (11.5) | 166 (26.5) | 135 (21.5) | 175 (27.9) |
It is acceptable that medical residents receive financial sponsoring from drug companies, because they haven't enough money to be informed (n = 625) | 162 (25.9) | 92 (14.7) | 107 (17.1) | 144 (23.1) | 120 (19.2) |
It is acceptable that medical residents receive financial sponsoring from drug companies, because drug companies have minimal influence on residents (n = 626) | 199 (31.8) | 156 (24.9) | 109 (17.4) | 112 (17.9) | 50 (8.0) |